At €98.05, Is Icade (EPA:ICAD) Worth Looking At Closely?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)At €98.05, Is Icade (EPA:ICAD) Worth Looking At Closely?Simply Wall StSimply Wall St.January 8, 2020ReblogShareTweetShareView photosIcade (EPA:ICAD), which is in the reits business, and is based in France, saw a significant share price rise of over 20% in the past couple of months on the ENXTPA. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s examine Icade’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. See our latest analysis for Icade What's the opportunity in Icade?Good news, investors! Icade is still a bargain right now. My valuation model shows that the intrinsic value for the stock is €131.34, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. What’s more interesting is that, Icade’s share price is theoretically quite stable, which could mean two things: firstly, it may take the share price a while to move to its intrinsic value, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.Can we expect growth from Icade?ENXTPA:ICAD Past and Future Earnings, January 8th 2020MoreInvestors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with a negative profit growth of -4.1% expected over the next couple of years, near-term growth certainly doesn’t appear to be a driver for a buy decision for Icade. This certainty tips the risk-return scale towards higher risk.What this means for you:Are you a shareholder? Although ICAD is currently undervalued, the adverse prospect of negative growth brings about some degree of risk. Consider whether you want to increase your portfolio exposure to ICAD, or whether diversifying into another stock may be a better move for your total risk and return.Are you a potential investor? If you’ve been keeping an eye on ICAD for a while, but hesitant on making the leap, I recommend you dig deeper into the stock. Given its current undervaluation, now is a great time to make a decision. But keep in mind the risks that come with negative growth prospects in the future.Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Icade. You can find everything you need to know about Icade in the latest infographic research report. If you are no longer interested in Icade, you can use our free platform to see my list of over 50 other stocks with a high growth potential.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextHere's What Absolent Group AB (publ)'s (STO:ABSO) P/E Is Telling UsSimply Wall St.Timeless Software (HKG:8028) Shareholders Have Enjoyed A 51% Share Price GainSimply Wall St.Is There Now An Opportunity In NetDragon Websoft Holdings Limited (HKG:777)?Simply Wall St.Imagine Owning CommsChoice Group (ASX:CCG) And Wondering If The 36% Share Price Slide Is JustifiedSimply Wall St.If You Had Bought Automated Systems Holdings (HKG:771) Stock A Year Ago, You'd Be Sitting On A 14% Loss, TodaySimply Wall St.Biocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWhy BE Group AB (publ) (STO:BEGR) Is A Dividend RockstarSimply Wall St.Most face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video